Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VD6Q
|
|||
| Drug Name |
RP103
|
|||
| Synonyms |
Cysteamine bitartrate; UNII-QO84GZ3TST; QO84GZ3TST; CYSTEAMINE BITARTRATE; Procysbi; Procysbi (TN); EINECS 248-641-7; Cysteamine bitartrate (JAN); beta-Mercaptoethylamine bitartrate; AKOS032954217; beta-Mercaptoethylamine hydrogen tartrate; D10468; Ethanethiol, 2-amino-, tartrate (1:1) (salt)
Click to Show/Hide
|
|||
| Indication | Huntington disease [ICD-11: 8A01.10; ICD-10: G10] | Phase 2/3 | [1] | |
| Company |
Raptor Therapeutics Novato, CA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C6H13NO6S
|
|||
| Canonical SMILES |
C(CS)N.C(C(C(=O)O)O)(C(=O)O)O
|
|||
| InChI |
1S/C4H6O6.C2H7NS/c5-1(3(7)8)2(6)4(9)10;3-1-2-4/h1-2,5-6H,(H,7,8)(H,9,10);4H,1-3H2/t1-,2-;/m1./s1
|
|||
| InChIKey |
NSKJTUFFDRENDM-ZVGUSBNCSA-N
|
|||
| CAS Number |
CAS 27761-19-9
|
|||
| PubChem Compound ID | ||||
| ADReCS Drug ID | BADD_D00557 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.